Kaleido Biosciences
- Biological Products, Except Diagnostic Substances
- Bedford, Massachusetts
Compensation history
Top executives at Kaleido Biosciences received an average of $3M per person in annual compensation from 2018 to 2020.
Average pay of disclosed executives at Kaleido Biosciences
By year
- 2020
DM$4MDaniel MenichellaPresident and Chief Executive Officer principal executive officerKK$2MKatharine KnobilFormer CMO & Head of R&DWD$1MWilliam Duke, JrChief Financial Officer principal financial officerAL$1MAlison LawtonFormer President and Chief Executive Officer former principal executive officer- 2019
AL$3MAlison LawtonPresident and Chief Executive Officer principal executive officerWD$2MWilliam Duke, JrChief Financial Officer principal financial officerJK$2MJerald KornGeneral Counsel and Corporate SecretaryKK$1MKatharine KnobilChief Medical Officer and Head of Research & DevelopmentJB$1MJoshua BrummChief Operating Officer and Chief Financial Officer former principal financial officer
Executives
We found six executives who work or worked at Kaleido Biosciences.
Daniel Menichella
Kaleido Biosciences
Chief Executive Officer
William Duke
Kaleido Biosciences
Chief Financial Officer
Katharine Knobil
Kaleido Biosciences
Chief Marketing Officer
Alison Lawton
Kaleido Biosciences
Chief Executive Officer
Jerald Korn
Kaleido Biosciences
General Counsel
Joshua Brumm
Kaleido Biosciences
Chief Financial Officer
News
About Kaleido Biosciences
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address18 Crosby Drive, Bedford, Massachusetts 01730
- Phone617-674-9000
- Fiscal year endDecember 31
Source: SEC filings on May 5, 2021 and May 8, 2020.